Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma-Reference-Cited by-同舟云学术

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma

Published:2016-05-22 Issue:23 Volume:7 Page:33542-33556
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Carita Guillaume¹,Frisch-Dit-Leitz Estelle²,Dahmani Ahmed¹,Raymondie Chloé¹,Cassoux Nathalie³,Piperno-Neumann Sophie⁴,Némati Fariba¹,Laurent Cécile⁵,De Koning Leanne⁶,Halilovic Ensar⁷,Jeay Sebastien⁷,Wylie Andrew⁷,Emery Caroline⁷,Roman-Roman Sergio²,Schoumacher Marie²,Decaudin Didier¹⁴

Affiliation:

1. Laboratory of preclinical investigation, Department of Translational Research, PSL University, Institut Curie, Paris, France

2. Department of Translational Research, Institut Curie, PSL University, Paris, France

3. Department of Ophthalmological Oncology, Institut Curie, Paris, France

4. Department of Medical Oncology, Institut Curie, Paris, France

5. Residual Tumor & Response to Treatment Lab, Department of Translational Research, Institut Curie, PSL University, Paris, Paris, France

6. RPPA Platform, Department of Translational Research, Institut Curie, PSL University, Paris, France

7. Novartis Institutes for Biomedical Research, Cambridge, MA USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15

2. Uveal melanoma modeling in mice and zebrafish;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

3. CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells;Cancers;2023-12-25

4. Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target;Cell Death Discovery;2023-06-16

5. A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma;British Journal of Cancer;2023-01-09